The Indian stock market extended its winning streak for the second consecutive week, with both the Sensex and Nifty gaining around 1% each. However, despite the overall strong performance, the markets failed to sustain early gains on Friday, closing in the red. The BSE Sensex slipped by 192 points to settle at 77,415, while the NSE Nifty declined by 73 points, ending at 23,519.
Several key stocks in the Nifty 50 faced notable declines this week, with Zomato, IndusInd Bank, and Cipla leading the losses. Let’s take a closer look at the top 10 losers of the Nifty 50 this week, according to Trendlyne.
Nifty 50 Top Losers This Week
Zomato
- Current Price: ₹201.7
- Weekly Change: -11.4%
Zomato faced a sharp decline this week, closing at ₹201.7.
IndusInd Bank
- Current Price: ₹649.9
- Weekly Change: -5.4%
IndusInd Bank saw a sharp decline of 5.4% this week.
Cipla
- Current Price: ₹1442.2
- Weekly Change: -5.4%
Cipla’s stock also saw a decline this week, shedding 5.4%.
Mahindra & Mahindra
- Current Price: ₹2665.8
- Weekly Change: -4.9%
Mahindra & Mahindra faced a tough week, witnessing a 4.9% dip.
Dr. Reddy’s Laboratories
- Current Price: ₹1144.2
- Weekly Change: -4.7%
Dr. Reddy’s Laboratories experienced a 4.7% decline.
Tata Motors
- Current Price: ₹674.5
- Weekly Change: -4.1%
Despite being a key player in the automobile industry, Tata Motors saw a decline of 4.1% this week.
Titan Company
- Current Price: ₹3063.4
- Weekly Change: -3.1%
Titan’s stock slid by 3.1% over the week.
Shriram Finance
- Current Price: ₹656.0
- Weekly Change: -3.1%
Shriram Finance saw a 3.1% dip.
Sun Pharmaceutical
- Current Price: ₹1734.7
- Weekly Change: -2.8%
Sun Pharmaceutical recorded a 2.8% fall this week.
Bajaj Auto
- Current Price: ₹7878.9
- Weekly Change: -2.3%
Bajaj Auto’s stock dropped by 2.3% this week.
Disclaimer: The information provided is for informational purposes only and should not be considered financial or investment advice. Stock market investments are subject to market risks. Always conduct your own research or consult a financial advisor before making investment decisions. Author or Business Upturn is not liable for any losses arising from the use of this information.
